|
RFC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.812300E-04 |
| Normal-vs-Stage3 |
1.62519997459754E-09 |
| Normal-vs-Stage4 |
2.426900E-04 |
| Stage1-vs-Stage2 |
9.774800E-01 |
| Stage1-vs-Stage3 |
6.718600E-01 |
| Stage1-vs-Stage4 |
2.346600E-01 |
| Stage2-vs-Stage3 |
7.830600E-01 |
| Stage2-vs-Stage4 |
4.139800E-01 |
| Stage3-vs-Stage4 |
3.417800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.11419770579369E-12 |
| Normal-vs-Asian |
4.109800E-02 |
| Caucasian-vs-AfricanAmerican |
8.397600E-01 |
| Caucasian-vs-Asian |
7.263000E-01 |
| AfricanAmerican-vs-Asian |
7.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.846600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.44809999547135E-08 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.62458935193399E-12 |
| Normal-vs-Extreme_Obese |
4.424100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.272600E-01 |
| Normal_Weight-vs-Obese |
1.189960E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.231600E-01 |
| Extreme_Weight-vs-Obese |
7.585600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.965700E-02 |
| Obese-vs-Extreme_Obese |
3.057800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9243000004554E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
8.442600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.793000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.523560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.423800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.551900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.388800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.794000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
4.23680002192839E-09 |
| Normal-VS-KIRP CIMP |
6.38099999999975E-05 |
| Normal-VS-Unclassified PRCC |
1.7058000001402E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.54129999985209E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.330600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.651670E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.537600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.568780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.206800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93099988724066E-11 |
| Normal-vs-N1 |
1.91950000338892E-08 |
| Normal-vs-N2 |
3.353900E-02 |
| N0-vs-N1 |
1.606960E-01 |
| N0-vs-N2 |
6.919600E-02 |
| N1-vs-N2 |
2.615800E-01 |
|
|
